Researchers have discovered the barrier to beta cell regeneration that could pave the way for improved treatment of diabetes and diseases that cause organ...
The Food and Drug Administration (FDA) has approved Zegalogue® (dasiglucagon) for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged...